- Home
- BFRI vs CELU Comparison
BFRI vs CELU Comparison
Compare BFRI & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BFRI | CELU |
|---|---|---|
| Founded | 1997 | 2016 |
| Country | United States | United States |
| Employees | 94 | 115 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.0M | 17.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BFRI | CELU |
|---|---|---|
| Price | $1.19 | $0.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.75 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 393.6K | 87.5K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.36 | N/A |
| Revenue Next Year | $16.98 | $76.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.57 | $0.56 |
| 52 Week High | $1.27 | $4.30 |
Technical Indicators
Market Signals| Indicator | BFRI | CELU |
|---|---|---|
| Relative Strength Index (RSI) | 61.55 | 41.17 |
| Support Level | $0.71 | $0.56 |
| Resistance Level | N/A | $0.85 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 74.55 | 28.44 |
Price Performance
Historical ComparisonAbout BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
About CELU Celularity Inc.
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.